prognostic factors

Open Access
Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival
CARSTEN NIEDER and KRISTIAN S. IMINGEN

In Vivo March 2023, 37 (2) 771-776; DOI: https://doi.org/10.21873/invivo.13140
Open Access
Clinicopathological Prognostic Factors Determining Outcomes of Treatment in Gastric Cancer Surgery
PIOTR KULIG, RADOSLAW PACH, OLIWIA MAJEWSKA and JAN KULIG

In Vivo November 2022, 36 (6) 2927-2935; DOI: https://doi.org/10.21873/invivo.13035
Open Access
Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers
DIRK RADES, BRITTA WARWAS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and FLORIAN CREMERS

In Vivo July 2022, 36 (4) 1795-1800; DOI: https://doi.org/10.21873/invivo.12894
Open Access
Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years
ELISA M. WERNER, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and DIRK RADES

In Vivo May 2022, 36 (3) 1297-1301; DOI: https://doi.org/10.21873/invivo.12830
You have access
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
CARSTEN NIEDER, ASTRID DALHAUG and BÅRD MANNSÅKER

In Vivo March 2022, 36 (2) 801-805; DOI: https://doi.org/10.21873/invivo.12766
You have access
Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer
SHINYA YAMAMOTO, TAKASHI CHISHIMA, YUKAKO SHIBATA, SHIORI INOUE, FUMI HARADA, HIDEKI TAKEUCHI, AKIMITSU YAMADA, KAZUTAKA NARUI and ITARU ENDO

In Vivo March 2022, 36 (2) 859-864; DOI: https://doi.org/10.21873/invivo.12774
You have access
Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region
CHRISTIAN STAACKMANN, STEVEN E. SCHILD and DIRK RADES

In Vivo July 2021, 35 (4) 2283-2288; DOI: https://doi.org/10.21873/invivo.12501
You have access
Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

In Vivo November 2020, 34 (6) 3719-3722; DOI: https://doi.org/10.21873/invivo.12220
You have access
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
NAOKI FUKUDA, KAZUHISA TODA, YU FUJIWARA, XIAOFEI WANG, AKIHIRO OHMOTO, TETSUYA URASAKI, NAOMI HAYASHI, YASUYOSHI SATO, KENJI NAKANO, MAYU YUNOKAWA, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI

In Vivo September 2020, 34 (5) 2859-2864; DOI: https://doi.org/10.21873/invivo.12113
You have access
Increased Expression of p-GSK3β Predicts Poor Survival in T –III/IV Stage OSCC Patients
BHARATH KUMAR VELMURUGAN, CHUN-WEN CHIU, YUEH-MIN LIN, MAHALAKSHMI BHARATH, CHUNG-MIN YEH, YU-EN CHEN, CHIA-MIN CHUNG and SHU-HUI LIN

In Vivo July 2020, 34 (4) 1805-1809; DOI: https://doi.org/10.21873/invivo.11975

Main menu

User menu

Search

prognostic factors

Pages